Literature DB >> 9227554

VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor.

M G Sirois1, E R Edelman.   

Abstract

Vascular endothelial growth factor (VEGF), a protein synthesized and secreted by a variety of normal and neoplastic cells, serves as an endothelial cell-specific mitogen and a potent angiogenic factor. Intradermal injection of VEGF increases vascular permeability, a critical event in inflammation and angiogenesis. We sought to identify which tissues are responsive to the inflammatory effect of VEGF, to investigate the mechanisms by which VEGF increases vascular permeability, and to establish whether mediators of inflammation such as platelet-activating factor (PAF) play a role in this regard. Intravenous injection of VEGF (0.001-0.1 nmol/kg) into rats induced dose-dependent protein extravasation in vascular beds of certain tissues up to 177% over control levels. In some tissues, the elevation in vascular permeability in vivo was abolished completely by selective PAF-receptor antagonists. Moreover, VEGF (10(-11) to 10(-9) M) was found to increase PAF synthesis in cultured bovine aortic endothelial cells up to 20-fold. Our results suggest that VEGF increases vascular permeability by inducing PAF synthesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227554     DOI: 10.1152/ajpheart.1997.272.6.H2746

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

Review 1.  Macular oedema: the role of soluble mediators.

Authors:  D Kent; S A Vinores; P A Campochiaro
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

Review 2.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

3.  PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer.

Authors:  Lei Sun; Zhen He; Jia Ke; Senmao Li; Xianrui Wu; Lei Lian; Xiaowen He; Xiaosheng He; Jiancong Hu; Yifeng Zou; Xiaojian Wu; Ping Lan
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 4.  VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications.

Authors:  Jincai Luo; Yan Xiong; Xiaofan Han; Yao Lu
Journal:  J Mol Med (Berl)       Date:  2011-03-02       Impact factor: 4.599

5.  VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2.

Authors:  P N Bernatchez; M V Winstead; E A Dennis; M G Sirois
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 6.  Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.

Authors:  Woo-Young Kim; Ho-Young Lee
Journal:  FEBS J       Date:  2009-07-31       Impact factor: 5.542

7.  Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.

Authors:  David S Gélinas; Pascal N Bernatchez; Simon Rollin; Nicolas G Bazan; Martin G Sirois
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

8.  Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma.

Authors:  Muriel Mathonnet; Bernard Descottes; Denis Valleix; Véronique Truffinet; Francois Labrousse; Yves Denizot
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

9.  Inhibition of prostaglandin G/H synthase unveils a potent effect of platelet activating factor on the permeability of bovine aortic endothelial cells to albumin.

Authors:  Pierre J Farmer; Daphné Girardot; Andrée Lepage; Domenico Regoli; Pierre Sirois
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

10.  Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Authors:  Vladislava O Melnikova; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.